Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Stockholder's Equity

v3.21.2
Consolidated Statements of Stockholder's Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income
Accumulated Deficit
Balance at beginning of period (in shares) at Dec. 31, 2019   71,931,000      
Balance at beginning of period at Dec. 31, 2019 $ 414,920 $ 7 $ 529,596 $ (887) $ (113,796)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   414,000      
Common stock issued pursuant to equity awards, net 2,612   2,612    
Stock-based compensation 6,827   6,827    
Other comprehensive income (loss) (733)     (733)  
Net income (loss) (15,469)       (15,469)
Balance at end of period (in shares) at Mar. 31, 2020   72,345,000      
Balance at end of period at Mar. 31, 2020 408,157 $ 7 539,035 (1,620) (129,265)
Balance at beginning of period (in shares) at Dec. 31, 2019   71,931,000      
Balance at beginning of period at Dec. 31, 2019 414,920 $ 7 529,596 (887) (113,796)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Other comprehensive income (loss) 437        
Net income (loss) (73,921)        
Balance at end of period (in shares) at Sep. 30, 2020   74,153,000      
Balance at end of period at Sep. 30, 2020 396,808 $ 7 584,968 (450) (187,717)
Balance at beginning of period (in shares) at Mar. 31, 2020   72,345,000      
Balance at beginning of period at Mar. 31, 2020 408,157 $ 7 539,035 (1,620) (129,265)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   597,000      
Common stock issued pursuant to equity awards, net 989   989    
Employee stock purchase plan (in shares)   161,000      
Employee stock purchase plan 2,141   2,141    
Stock-based compensation 12,085   12,085    
Other comprehensive income (loss) 410     410  
Net income (loss) (21,807)       (21,807)
Balance at end of period (in shares) at Jun. 30, 2020   73,103,000      
Balance at end of period at Jun. 30, 2020 401,975 $ 7 554,250 (1,210) (151,072)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   246,000      
Common stock issued pursuant to equity awards, net (507)   (507)    
Common stock issued for merger, net (in shares)   804,000      
Common stock issued for merger, net 17,080   17,080    
Stock-based compensation 14,145   14,145    
Other comprehensive income (loss) 760     760  
Net income (loss) (36,645)       (36,645)
Balance at end of period (in shares) at Sep. 30, 2020   74,153,000      
Balance at end of period at Sep. 30, 2020 396,808 $ 7 584,968 (450) (187,717)
Balance at beginning of period (in shares) at Dec. 31, 2020   74,536,000      
Balance at beginning of period at Dec. 31, 2020 391,117 $ 7 602,064 1,435 (212,389)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   917,000      
Common stock issued pursuant to equity awards, net 16,566 $ 1 16,565    
Repurchase of common stock (in shares)   (75,000)      
Repurchase of common stock (2,673)   (2,673)    
Stock-based compensation 12,955   12,955    
Other comprehensive income (loss) (989)     (989)  
Net income (loss) 3,802       3,802
Balance at end of period (in shares) at Mar. 31, 2021   75,378,000      
Balance at end of period at Mar. 31, 2021 420,778 $ 8 628,911 446 (208,587)
Balance at beginning of period (in shares) at Dec. 31, 2020   74,536,000      
Balance at beginning of period at Dec. 31, 2020 $ 391,117 $ 7 602,064 1,435 (212,389)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Repurchase of common stock (in shares) (219,100)        
Repurchase of common stock $ (8,100)        
Other comprehensive income (loss) (924)        
Net income (loss) 13,793        
Balance at end of period (in shares) at Sep. 30, 2021   76,735,000      
Balance at end of period at Sep. 30, 2021 457,543 $ 8 655,620 511 (198,596)
Balance at beginning of period (in shares) at Mar. 31, 2021   75,378,000      
Balance at beginning of period at Mar. 31, 2021 420,778 $ 8 628,911 446 (208,587)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   1,098,000      
Common stock issued pursuant to equity awards, net (338)   (338)    
Repurchase of common stock (in shares)   (120,000)      
Repurchase of common stock (4,464)   (4,464)    
Employee stock purchase plan (in shares)   113,000      
Employee stock purchase plan 2,635   2,635    
Stock-based compensation 13,966   13,966    
Other comprehensive income (loss) 357     357  
Net income (loss) 733       733
Balance at end of period (in shares) at Jun. 30, 2021   76,469,000      
Balance at end of period at Jun. 30, 2021 433,667 $ 8 640,710 803 (207,854)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Common stock issued pursuant to equity awards, net (in shares)   290,000      
Common stock issued pursuant to equity awards, net $ (104)   (104)    
Repurchase of common stock (in shares) (24,200) (24,000)      
Repurchase of common stock $ (1,008)   (1,008)    
Stock-based compensation 16,022   16,022    
Other comprehensive income (loss) (292)     (292)  
Net income (loss) 9,258       9,258
Balance at end of period (in shares) at Sep. 30, 2021   76,735,000      
Balance at end of period at Sep. 30, 2021 $ 457,543 $ 8 $ 655,620 $ 511 $ (198,596)